|
Diabetes, Vol 45, Issue 7 869-875, Copyright © 1996 by American Diabetes Association
Effect of IGF-I on phosphatidylinositol 3-kinase in soleus muscle of lean and insulin-resistant obese mice
D Jullien, SJ Heydrick, N Gautier, E Van Obberghen and Y Le Marchand-Brustel
Institut National de la Sante et de la Recherche Medicale, Faculty ofMedicine, Nice, France.
Insulin and IGF-I induced a similar stimulation of glucose transport in
isolated soleus muscle. These actions require phosphatidylinositol (PI)
3-kinase activation since the PI 3-kinase inhibitor, wortmannin, blocked
the stimulation by both peptides. We compared IGF-I with insulin in the
ability to activate PI 3-kinase in the isolated soleus muscle from lean and
gold thioglucose-induced obese insulin-resistant mice. In muscles from lean
mice, IGF-I and insulin were able to activate PI 3-kinase with a similar
time course, the effects being maximal within 3-5 min of stimulation.
However, the IGF-I concentrations required to obtain similar effects on PI
3-kinase were about 10 times higher than the corresponding insulin doses.
To determine through which receptor IGF-I was activating PI 3-kinase, the
ability of IGF-I to activate both its own receptor and insulin receptor was
simultaneously measured. Whatever the dose used (100 or 500 nmol/l), IGF-I
activated to a nearly similar extent both the tyrosine kinase activity of
its own receptor and that of the insulin receptor, suggesting that IGF-I
was not only activating its receptor but was also able to stimulate the
insulin receptor kinase. In muscles of obese insulin-resistant mice,
although the defect of PI 3-kinase activation in response to IGF-I was
relatively less pronounced (45%) than in response to insulin (70%) when
compared with lean mice, PI 3-kinase stimulation was still markedly altered
in response to IGF-I.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Yoshida, K. Murao, H. Imachi, W. M. Cao, X. Yu, J. Li, R. A. M. Ahmed, N. Kitanaka, N. C. W. Wong, T. G. Unterman, et al.
Pancreatic Glucokinase Is Activated by Insulin-Like Growth Factor-I
Endocrinology,
June 1, 2007;
148(6):
2904 - 2913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kido, J. Nakae, M. L. Hribal, S. Xuan, A. Efstratiadis, and D. Accili
Effects of Mutations in the Insulin-like Growth Factor Signaling System on Embryonic Pancreas Development and beta -Cell Compensation to Insulin Resistance
J. Biol. Chem.,
September 20, 2002;
277(39):
36740 - 36747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Pratipanawatr, W. Pratipanawatr, C. Rosen, R. Berria, M. Bajaj, K. Cusi, L. Mandarino, S. Kashyap, R. Belfort, and R. A. DeFronzo
Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects
Am J Physiol Endocrinol Metab,
June 1, 2002;
282(6):
E1360 - E1368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Fernandez, J. K. Kim, S. Yakar, J. Dupont, C. Hernandez-Sanchez, A. L. Castle, J. Filmore, G. I. Shulman, and D. Le Roith
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
Genes & Dev.,
August 1, 2001;
15(15):
1926 - 1934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Vary, L. S. Jefferson, and S. R. Kimball
Role of eIF4E in stimulation of protein synthesis by IGF-I in perfused rat skeletal muscle
Am J Physiol Endocrinol Metab,
January 1, 2000;
278(1):
E58 - E64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Christopher, F. L. Hew, M. Oakley, C. Rantzau, and F. Alford
Defects of Insulin Action and Skeletal Muscle Glucose Metabolism in Growth Hormone-Deficient Adults Persist after 24 Months of Recombinant Human Growth Hormone Therapy
J. Clin. Endocrinol. Metab.,
May 1, 1998;
83(5):
1668 - 1681.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K.-C. Leung, M. J. Waters, I. Markus, W. R. Baumbach, and K. K. Y. Ho
Insulin and insulin-like growth factor-I acutely inhibit surface translocation of growth hormone receptors in osteoblasts: A novel mechanism of growth hormone receptor regulation
PNAS,
October 14, 1997;
94(21):
11381 - 11386.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Diabetes Association.
|
|
| |
|